CDT Equity (CDT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.24, +12.49% vs the prior close of $0.21.
- Volume 11.68M shares, 15.2x its 50-day average (heavy).
- New SEC filings: PRE 14A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
CDT jumps 12.5% to $0.24 on 15.2x normal volume. Closed at $0.24, +12.49% vs the prior close of $0.21. Day range $0.19–$0.24, opened at $0.20.
CDT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CDT jumps 12.5% to $0.24 on 15.2x normal volume
- Closed at $0.24, +12.49% vs the prior close of $0.21. Day range $0.19–$0.24, opened at $0.20.
- Volume was 11.68M shares, 15.2x its 50-day average of 766.82K — unusually heavy trading.
- Price is -99.1% vs its 50-day average ($26.17) and -100.0% vs its 200-day average ($1,995.79).
- 52-week range $0.18–$28,125.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
Oct 15, 2026 — CDT slides 12.9% to $0.21, a 52-week low on 3.0x normal volume
- Closed at $0.21, -12.92% vs the prior close of $0.24. Day range $0.18–$0.22, opened at $0.20.
- Volume was 2.18M shares, 3.0x its 50-day average of 722.92K — unusually heavy trading.
- Price is -99.2% vs its 50-day average ($27.78) and -100.0% vs its 200-day average ($2,036.73).
- 52-week range $0.18–$28,125.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 — CDT slides 46.7% to $0.24, a 52-week low on 81.0x normal volume
- Closed at $0.24, -46.67% vs the prior close of $0.45. Day range $0.19–$0.25, opened at $0.24.
- Volume was 22.35M shares, 81.0x its 50-day average of 276.04K — unusually heavy trading.
- Price is -99.2% vs its 50-day average ($29.57) and -100.0% vs its 200-day average ($2,081.10).
- 52-week range $0.19–$28,125.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — CDT slides 31.8% to $0.45, a 52-week low on 3.8x normal volume
- Closed at $0.45, -31.82% vs the prior close of $0.66. Day range $0.41–$0.61, opened at $0.59.
- Volume was 966.40K shares, 3.8x its 50-day average of 256.76K — unusually heavy trading.
- Price is -98.6% vs its 50-day average ($31.14) and -100.0% vs its 200-day average ($2,125.79).
- 52-week range $0.41–$28,125.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — CDT slides 8.1% to $0.66, a 52-week low, 4 down days in a row
- Closed at $0.66, -8.08% vs the prior close of $0.72. Day range $0.63–$0.71, opened at $0.70.
- Volume was 365.00K shares, 1.5x its 50-day average of 249.56K.
- Price is -98.0% vs its 50-day average ($32.56) and -100.0% vs its 200-day average ($2,175.47).
- 52-week range $0.63–$28,400.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — CDT slides 10.3% to $0.72, a 52-week low on 1.9x normal volume
- Closed at $0.72, -10.25% vs the prior close of $0.80. Day range $0.70–$0.80, opened at $0.79.
- Volume was 466.40K shares, 1.9x its 50-day average of 240.25K — unusually heavy trading.
- Price is -97.9% vs its 50-day average ($34.01) and -100.0% vs its 200-day average ($2,224.84).
- 52-week range $0.70–$33,450.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — CDT slides 4.3% to $0.80, a 52-week low
- Closed at $0.80, -4.31% vs the prior close of $0.84. Day range $0.80–$0.85, opened at $0.82.
- Volume was 263.10K shares, 1.1x its 50-day average of 235.05K.
- Price is -97.7% vs its 50-day average ($35.34) and -100.0% vs its 200-day average ($2,277.03).
- 52-week range $0.80–$37,500.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
Oct 7, 2026 — CDT slides 10.1% to $0.84, a 52-week low on 2.1x normal volume
- Closed at $0.84, -10.11% vs the prior close of $0.93. Day range $0.80–$0.90, opened at $0.90.
- Volume was 481.80K shares, 2.1x its 50-day average of 225.47K — unusually heavy trading.
- Price is -97.7% vs its 50-day average ($36.60) and -100.0% vs its 200-day average ($2,327.96).
- 52-week range $0.80–$39,450.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
Oct 6, 2026 — CDT rises 1.3% to $0.93 on 4.4x normal volume
- Closed at $0.93, +1.31% vs the prior close of $0.92. Day range $0.85–$0.94, opened at $0.90.
- Volume was 918.30K shares, 4.4x its 50-day average of 207.12K — unusually heavy trading.
- Price is -97.6% vs its 50-day average ($38.05) and -100.0% vs its 200-day average ($2,380.46).
- 52-week range $0.85–$44,450.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
Oct 5, 2026 — CDT slides 7.3% to $0.92, a 52-week low, 20 down days in a row
- Closed at $0.92, -7.27% vs the prior close of $0.99. Day range $0.85–$0.97, opened at $0.97.
- Volume was 352.80K shares, 1.8x its 50-day average of 200.09K.
- Price is -97.7% vs its 50-day average ($39.46) and -100.0% vs its 200-day average ($2,431.39).
- 52-week range $0.85–$44,450.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 20 straight losses.
Oct 2, 2026 — CDT slides 20.8% to $0.99, a 52-week low on 5.7x normal volume
- Closed at $0.99, -20.80% vs the prior close of $1.25. Day range $0.95–$1.28, opened at $1.28.
- Volume was 1.03M shares, 5.7x its 50-day average of 179.62K — unusually heavy trading.
- Price is -97.6% vs its 50-day average ($40.97) and -100.0% vs its 200-day average ($2,484.82).
- 52-week range $0.95–$44,450.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 20 straight losses.
CDT latest news & SEC filings
Every SEC filing by or about CDT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Oct 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Oct 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 18, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Sep 18, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 9, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 8, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade CDT
- How much it moves: over the last 20 sessions the average daily move was 13.87% (largest 46.7%). That is a volatile stock.
- Liquidity: about 2.30M shares (≈$540.65K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.24 vs a range of $0.18–$28,125.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Sep 29, 2026, 1:10 on Jul 20, 2026, 1:25 on Mar 27, 2026, 1:8 on Oct 13, 2025, 1:15 on May 20, 2025, 1:100 on Jan 27, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Andrew Regan sold 290 shares on Aug 28, 2026.
- Latest filings: 8-K Oct 13, 2026; 8-K Sep 25, 2026; 8-K Sep 18, 2026.
- Share count: 786.67K shares outstanding (Aug 12, 2026), -74.3% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CDT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.20 | 0.24 | 0.19 | 0.24 | 11.68M |
| Oct 15, 2026 | 0.20 | 0.22 | 0.18 | 0.21 | 2.21M |
| Oct 14, 2026 | 0.24 | 0.25 | 0.19 | 0.24 | 22.35M |
| Oct 13, 2026 | 0.59 | 0.61 | 0.41 | 0.45 | 966.40K |
| Oct 12, 2026 | 0.70 | 0.71 | 0.63 | 0.66 | 365.00K |
| Oct 9, 2026 | 0.79 | 0.80 | 0.70 | 0.72 | 466.40K |
| Oct 8, 2026 | 0.82 | 0.85 | 0.80 | 0.80 | 263.10K |
| Oct 7, 2026 | 0.90 | 0.90 | 0.80 | 0.84 | 481.80K |
| Oct 6, 2026 | 0.90 | 0.94 | 0.85 | 0.93 | 918.30K |
| Oct 5, 2026 | 0.97 | 0.97 | 0.85 | 0.92 | 352.80K |
| Oct 2, 2026 | 1.28 | 1.28 | 0.95 | 0.99 | 1.03M |
| Oct 1, 2026 | 1.34 | 1.37 | 1.22 | 1.25 | 259.10K |
| Sep 30, 2026 | 1.45 | 1.56 | 1.34 | 1.36 | 327.20K |
| Sep 29, 2026 | 1.87 | 1.88 | 1.44 | 1.45 | 599.80K |
| Sep 28, 2026 | 1.88 | 1.92 | 1.70 | 1.90 | 1.22M |
| Sep 25, 2026 | 2.20 | 2.22 | 1.98 | 2.00 | 1.07M |
| Sep 24, 2026 | 3.03 | 3.17 | 3.00 | 3.03 | 295.77K |
| Sep 23, 2026 | 3.45 | 3.60 | 3.28 | 3.38 | 466.03K |
| Sep 22, 2026 | 3.75 | 3.75 | 3.25 | 3.55 | 500.62K |
| Sep 21, 2026 | 4.15 | 4.25 | 3.83 | 3.85 | 179.24K |
About CDT Equity
CDT Equity (CDT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NAPLES, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1896212.
CDT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chele Chiavacci Farley | Director | Feb 23, 2026 |
| Ulrik K Olsen | Director | Apr 30, 2026 |
| Andrew Regan | Chief Executive Officer | Sep 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Andrew Regan | Chief Executive Officer | Sep 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Andrew Regan | Sale | 290 | — |
| Aug 28, 2026 | Andrew Regan | Sale | 290 | — |
| Aug 28, 2026 | Andrew Regan | Sale | 290 | — |
| Aug 28, 2026 | Andrew Regan | Sale | 290 | — |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 5,000 | $0.75 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 1,464,711 | $1.44 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 593,289 | $1.40 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 5,000 | $0.71 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 5,000 | $0.75 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 1,464,711 | $1.44 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 593,289 | $1.40 |
| Jun 18, 2026 | Capital Securities Ltd Prospect | Sale | 5,000 | $0.71 |
| Jun 18, 2026 | Finance Ltd Prospect | Sale | 5,000 | $0.75 |
| Jun 18, 2026 | Finance Ltd Prospect | Sale | 1,464,711 | $1.44 |
| Jun 18, 2026 | Finance Ltd Prospect | Sale | 593,289 | $1.40 |
CDT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-39.22M | -1,177.89 | $-15.55M |
| Dec 31, 2024 | — | $-17.80M | -61,598.62 | $-9.68M |
| Dec 31, 2023 | — | $-535.00K | -8.92 | $-7.72M |
| Dec 31, 2022 | — | $-4.89M | -0.13 | $-2.27M |
Latest balance sheet: total assets $126.71M, total liabilities $23.61M, cash $747.00K (as of Jun 30, 2026).
CDT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CDT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.